Evidence map›Paper›PMID 40379646›Full record

ArticleMicrosystems & nanoengineering2025

Combining time domain modulation optofluidics and high dynamic range imaging for multiplexed, high throughput digital droplet assays.

Yasemin Atiyas, Michael J Siedlik, Stephanie J Yang, David A Issadore

Abstract read
In one paragraph

Article in Microsystems & nanoengineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yasemin AtiyasDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Michael J SiedlikInfiniFluidics Inc., Philadelphia, PA, 19146, USA.
Stephanie J YangDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA, 19104, USA.
David A IssadoreDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA, 19104, USA. issadore@seas.upenn.edu.

Funding

Nanomagnetic isolation and sensing for mobile HIV-1 self-testingR33AI147406 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ISSADORE, DAVID AARON · 2022 to 2023
$1.6M
High Throughput Digital Droplet Assays for Ultrasensitive Multimodal (DNA, RNA, and Protein) DiagnosticsR33CA287135 · NCI · UNIVERSITY OF PENNSYLVANIA · PI David Aaron Issadore · 2024 to 2026
$1.2M
Combining Machine Learning and Nanofluidic Technology for The Multiplexed Diagnosis of Pancreatic AdenocarcinomaR33CA278551 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CARPENTER, ERICA, ISSADORE, DAVID AARON · 2023 to 2025
$1.1M
High-throughput and multiplex single-molecule quantification and sorting of single EVR61CA302620 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ISSADORE, DAVID AARON · 2025 to 2025
$626k
High Throughput Digital Droplet ELISA for Ultrasensitive Multiplexed DiagnosticsR21CA236653 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ISSADORE, DAVID AARON · 2020 to 2022
$578k
NCI NIH HHS R33 CA287135NCI NIH HHS R61 CA302620NIAID NIH HHS R33 AI147406U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R21CA236653U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R33CA278551U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI) RM1-HG-010023
6 · The paper itself

Abstract

Digital enzyme-linked immunoassays (dELISA) have been successfully applied to the ultrasensitive quantification of analytes, including nucleic acids, proteins, cells, and extracellular vesicles, achieving robust detection limits in complex clinical specimens such as blood, and demonstrating utility across a broad range of clinical applications. The ultrasensitivity of dELISA comes from partitioning single analytes, captured onto a microbead, into millions of compartments so that they can be counted individually. There is particular interest in using dELISA for multiplexed measurements, but generating and detecting the billions of compartments necessary to perform multiplexed ultrasensitive dELISA remains a challenge. To address this, we have developed a high-throughput, optofluidic platform that performs quantitative fluorescence measurements on five populations of microbeads, each encoded with distinct ratios of two fluorescent dyes, for digital assays. The key innovation of our work is the parallelization of droplet generation and detection, combined with time-domain encoding of the excitation sources into distinct patterns that barcode the emission signal of both dyes within each bead, achieving high throughput (6 × 10

Identifiers

PMID40379646
PMCPMC12084528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.